These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2026664)

  • 1. Very broad Markush claims; a solution or a problem? Proceedings of a round-table discussion held on August 29, 1990.
    Milne GW
    J Chem Inf Comput Sci; 1991 Feb; 31(1):9-30. PubMed ID: 2026664
    [No Abstract]   [Full Text] [Related]  

  • 2. Intuitive patent Markush structure visualization tool for medicinal chemists.
    Deng W; Berthel SJ; So WV
    J Chem Inf Model; 2011 Mar; 51(3):511-20. PubMed ID: 21381694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PHARMSEARCH database.
    O'Hara MP; Pagis C
    J Chem Inf Comput Sci; 1991 Feb; 31(1):59-63. PubMed ID: 2026662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of different approaches to Markush structure handling.
    Barnard JM
    J Chem Inf Comput Sci; 1991 Feb; 31(1):64-8. PubMed ID: 2026663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vinyl chloride and chemical industry in the United States and in Europe: proofs of illegal conspiracy of companies].
    Markowitz G; Rosner D
    Epidemiol Prev; 2001; 25(4-5):191-203. PubMed ID: 11789459
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene patents: socially acceptable monopolies or an unnecessary hindrance to research?
    Williamson AR
    Trends Genet; 2001 Nov; 17(11):670-3. PubMed ID: 11672868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roche claims victory in bid for European Taq patent.
    Dickson D
    Nature; 1996 Nov; 384(6605):100. PubMed ID: 8906775
    [No Abstract]   [Full Text] [Related]  

  • 9. Reach-through claims: how far a reach?
    Becker DM
    Nat Rev Drug Discov; 2004 Aug; 3(8):639. PubMed ID: 15317146
    [No Abstract]   [Full Text] [Related]  

  • 10. Property claims. A deluge of patents creates legal hassles for research.
    Marshall E
    Science; 2000 Apr; 288(5464):255-7. PubMed ID: 10777404
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinase patent space visualization using chemical replacements.
    Southall NT; Ajay
    J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inventive step and genomics.
    Soames CJ; Kowalski TJ
    Nat Rev Drug Discov; 2004 Sep; 3(9):729. PubMed ID: 15368655
    [No Abstract]   [Full Text] [Related]  

  • 13. [COMPARISON OF 2 BILLS ON PHARMACEUTICAL PATENTING IN ITALY, THE EUROPEAN PATENT BILL AND THE GERMAN, ENGLISH AND UNITED STATES LAWS ON PATENTS OF INVENTIONS].
    BELLENGHI M
    Farmaco Prat; 1964 May; 19():240-51. PubMed ID: 14167551
    [No Abstract]   [Full Text] [Related]  

  • 14. German agencies sound alarm on risks of broad gene patents...as spending goes up for research.
    Schiermeier Q
    Nature; 2000 Jul; 406(6792):111. PubMed ID: 10910319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Patents in the chemical pharmaceutical industry].
    ZELLER-CELSO L
    Farmaco Sci Tec; 1951; 6(7):974-81. PubMed ID: 14954939
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced graphs and their applications in chemoinformatics.
    Birchall K; Gillet VJ
    Methods Mol Biol; 2011; 672():197-212. PubMed ID: 20838970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Markush structure analysis techniques for descriptor generation and clustering of large combinatorial libraries.
    Barnard JM; Downs GM; von Scholley-Pfab A; Brown RD
    J Mol Graph Model; 2000; 18(4-5):452-63. PubMed ID: 11143562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
    Minssen T; Kesselheim AS; Darrow JJ
    Nat Biotechnol; 2019 Jan; 37(1):21-22. PubMed ID: 30605154
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemispherx: 300 patents, 20 staff.
    Chahine K
    Nat Biotechnol; 1997 Jul; 15(7):612-3. PubMed ID: 9219255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.